1. Introduction {#sec1}
===============

*Panax notoginseng* (Burk.) F. H. Chen has been domesticated and cultivated in Southwestern China for more than 400 years. Sanqi or Tianqi is known as a famous araliaceous traditional Chinese medicinal (TCM) herb , and its roots have been used widely as a tonic and hemostatic agent and one of the major ingredients of Danshen dripping pill, a traditional Chinese medicinal preparation for treating common cardiovascular diseases in the world, e.g., China, Korea, and Russia [@bib1]. Owing to its sensitivity to sunlight, heat, and humidity, the plantation of Sanqi is restricted to Southwest China, and the root is susceptible to various diseases [@bib2], particularly, root rot disease, caused mainly by infection by plant pathogens; this is not only the most serious destructive disease of Sanqi in its cultivated regions of China but also a big problem affecting the industrialization of this precious medicinal material because it may cause the loss of production accounting for an average of 20%, even up to 70% in severe situation [@bib3], [@bib4].

To date, more than 200 saponins, flavonoids, polyacetylenes, cyclopeptides, and amino acids have been identified in Sanqi. Among which, dammarane triterpenoid saponins are the major and bioactive secondary metabolites in the roots [@bib5], with ginsenosides Rb1, Re, Rd, and Rg1 and notoginsenoside R1 as the five defining saponins. Our previous work on steam-processed Sanqi roots resulted in a series of new transformed saponins with promoting effects on the differentiation of PC12 cells [@bib6], [@bib7]. Moreover, high performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry (HPLC--QTOF/MS) comparison showed that the oxidation level of the chemical constituents in Sanqi roots significantly increased after being infected by the root rot disease [@bib8]. To search for new bioactive components and to clarify the discrepancy and their transformation mechanisms in the rot roots of *P. notoginseng*, a detailed chemical investigation was carried out. This led to the isolation of 30 dammarane triterpenes ([Fig. 1](#fig1){ref-type="fig"}), including four saponins (**10**, **15**, **18**, and **20**) and 10 hydroperoxylated (**1**--**4** and **13**--**18**) and seven 20,24-epoxylated (**5**--**6** and **26**--**30**) analogs. Of them, four hydroperoxylated (**1**--**4**) and two 20,24-epoxylated (**5**--**6**) derivatives are new compounds, together with **7,** who is losing of the side chain from C-22 to C-27.Fig. 1Compounds **1**--**30** from the rot roots of *P. notoginseng*. (Glc, *β*-D-glucopyranosyl).Fig. 1

The 20(*S*)-protopanaxadiol (PPD), being reported with stronger cytotoxicity on leukemia THP-1 cells [@bib9], has been developed as an anticancer drug candidate [@bib10]. Moreover, compound K (CK) and ginsenosides Rh1 and Rg1 were reported to inhibit the NO production in RAW264.7 cells [@bib11], [@bib12]. Herein, all isolates were assayed for the antiinflammatory and cytotoxic activities, which might provide new candidates for searching antiinflammatory and antitumor agents and basic theory for the scientific utilization of rot roots of *P. notoginseng*.

2. Materials and methods {#sec2}
========================

2.1. General experimental procedures {#sec2.1}
------------------------------------

Optical rotations, IR, and UV spectra were recorded on a JASCO P-1020 polarimeter (Tokyo, Japan), Hercules Bio-Rad FTS-135 series spectrometer (CA, USA), and Shimadzu UV-2401 PC ultraviolet--visible spectrophotometer (Tokyo, Japan), respectively. Electrospray ionization mass spectra (ESI-MS) and high-resolution electrospray ionization mass spectra (HR-ESI-MS) were carried out on an Agilent G6230 TOF MS spectrometer. 1D- and 2D-NMR spectra were recorded on a Bruker DRX-500, 600 or 800 spectrometer (Karlsruhe, Germany). The X-ray diffraction instrument (Bruker APEX DUO, Karlsruhe, Germany) was used for characterizing the structures of the crystal. Macroporous resin D101 and silica gel (200--300 mesh) were used for column chromatography (CC), and TLC analysis with silica gel GF254 plates were visualized by heating after spraying with 10% H~2~SO~4~/EtOH. All CC and TLC materials were purchased from Qingdao Haiyang Chemical Co. Ltd., China. Reverse-phase semipreparative HPLC (Capcell Pak MGII C~18~ column, 5 μm, 250 mm × 10 mm, Tokyo, Japan) was performed on a Hanbon series (Jiangsu Hanbon Science & Technology Co., China) at 25 °C with a flowing rate of 3.0 mL/min.

2.2. Plant material {#sec2.2}
-------------------

Rot roots of *Panax notoginseng*, identiﬁed by Prof. C.R. Yang of Kunming Institute of Botany (KIB), Chinese Academy of Sciences, were collected in Wenshan District, Yunnan Province, China, on February 2017. A voucher specimen (KIB-Z-2017001) was deposited in the State Key Laboratory of Phytochemistry and Plant Resource in West China of KIB, Chinese Academy of Sciences.

2.3. Extraction and isolation {#sec2.3}
-----------------------------

The fresh rot roots (70 kg) were cut from the healthy part, air-dried under room temperature, and extracted with MeOH under reflux (× 3). The MeOH extract (4.0 kg) was loaded to a macroporous resin D101 column, eluting with H~2~O to remove the saccharide portion and then with MeOH to give the total saponin fraction (Fr.) (2.7 kg). Further silica gel CC (250 × 30 cm) with CHCl~3~-MeOH (7:3) of the MeOH fraction gave Fr. A--Fr. C. TLC and HPLC analysis showed Fr. C (220.8 g) containing mainly notoginsenoside R1 and ginsenosides Rg1, Re, Rd, and Rb1.

Fr. B (62.1 g) was fractionated by CC of RP-18 (MeOH-H~2~O, 1:9 to 9:1) to yield eight subfractions (Fr. B1--B8). Fr. B1 (1.5 g) was subjected to silica gel (CHCl~3~-MeOH, 10:1) and RP-18 (MeOH-H~2~O, 1:1 to 9:1), followed by semipreparative HPLC (MeCN-H~2~O, 2:8) to yield **2** (2.2 mg), **3** (3.1 mg), and **20** (12 mg). Fr. B3 (10 g) was chromatographed over silica gel CC (CHCl~3~-MeOH, 200:1 to 95:5) and semipreparative HPLC (MeCN-H~2~O, 35:65) to yield **1** (10 mg), **9** (100 mg), **11** (65 mg), **17** (22 mg), **18** (3 mg), and **24** (15 mg). Compounds **10** (120 mg) and **15** (13 mg) from Fr. B2 (2.0 g), and **7** (18 mg) and **19** (120 mg) from Fr. B4 (1.1 g), were obtained by silica gel CC, eluting with CHCl~3~-MeOH (100:1 to 10:1, 200:1 to 95:5). Subfractions of Frs. B5.1--5.5, Frs. B6.1--6.5, and Frs. B7.1--7.5 were yielded separately by silica gel CC (CHCl~3~-MeOH, 200:1 to 50:1) from Fr. B5 (1.5 g), Fr. B6 (1.0 g), and Fr. B7 (1.2 g). Furthermore, RP-18 CC (MeOH-H~2~O, 9:1 to 20:1 and 50:50) gave **8** (80 mg) from Fr. B5.2 (230 mg) and **6** (2.3 mg) and **12** (30 mg) from Fr. B7.3 (80 mg). Semipreparative HPLC (MeCN-H~2~O, 43:57) resulted in **4** (1.0 mg), **13** (19 mg), **14** (11 mg), **16** (36 mg), and **23** (8.2 mg) from Fr. B5.5, and **5** (2.0 mg), **26** (2.5 mg), **28** (4.0 mg), and **29** (2.3 mg) from Fr. B7.4 (250 mg). Crystal **30** (116 mg) was obtained from Fr. B6.3 (370 mg) by recrystallization in CHCl~3~-MeOH (1:1). Compounds **22** (9.0 mg) and **27** (100 mg) from Fr. B6.4 (210 mg), and **21** (32 mg) and **25** (18 mg) from Fr. B6.5 (70 mg) were obtained by semipreparative HPLC (MeCN-H~2~O, 33:67 and 52:48).

2.4. 20(S)-dammar-25-ene-24(S)-hydroperoxyl-3β,6α,12β,20-tetrol (**1**) {#sec2.4}
-----------------------------------------------------------------------

White amorphous powder; \[*a*\]$25\ \text{D}$ +26.8 (*c* 0.12, MeOH); UV (MeOH) λ~max~ (log *ε*) 203 (0.16) nm; IR (KBr) *ν*~max~ 3416, 2961, 2932, 2876, 1648, 1631, 1465, 1451, 1384 cm^−1^; ^1^H and ^13^C NMR data are shown in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}; HR-ESI-MS *m/z* 531.3659 \[M+Na\]^+^ (calcd for C~30~H~52~O~6~Na, 531.3662).Table 1^1^H NMR (600 MHz, 800 MHz, and 500 MHz in C~5~D~5~N) data for compounds **1**--**7** (*δ* in ppm, *J* in hertz)Table 1No.1234[a](#tbl1fna){ref-type="table-fn"}567[b](#tbl1fnb){ref-type="table-fn"}11.07 m1.61 m0.96 m1.33 m1.95 m1.82 m1.48 m1.70 m1.76 m1.44 m1.79 m3.20 m3.11 m2.25 m21.88 m, 1.95 m2.31 m, 2.84 m1.87 m1.51 m, 2.46 m2.56 m, 3.02 m2.40 m, 2.88 m2.27 m, 2.77 m33.56 dt (11.8,5.1)3.51 dt (11.5,4.6)51.26 d (10.4)1.96 d (10.6)1.25 d (10.5)1.38 m1.69 m1.62 m1.91 m64.44 m4.25 m4.47 m1.42 m, 1.50 m1.68 m1.62 m4.25 m71.91 m, 1.99 m1.92 m1.97 m1.28 m, 2.51 m1.30 m, 1.48 m1.29 m, 1.46 m1.86 m91.62 m1.71 m1.91 m1.55 m2.20 m2.13 m1.90 m111.60 m, 2.17 m1.61 m, 2.12 m2.37 m, 2.40 m1.62 m, 2.07 m2.42 m, 2.59 m2.40 m, 2.47 m1.89 m, 2.24 m123.95 m3.95 m3.93 m132.08 t (10.6)2.08 m3.37 d (9.7)2.08 m3.24 d (9.0)3.23 d (9.4)3.27 d (12.0)151.04 m, 1.57 m1.08 m, 1.63 m1.18 m, 1.91 m1.08 m, 1.64 m1.16 m, 1.79 m1.16 m, 1.80 m1.13 m, 1.72 m161.37 m, 1.86 m1.48 m, 1.88 m1.90 m, 2.09 m1.49 m, 1.91 m1.82 m1.82 m1.71 m, 1.97 m172.36 dt (18.0,7.2)2.40 dt (18.0,7.2)2.74 m2.39 dt (18.0,7.2)2.78 dd (16.2,7.2)2.78 m3.37 m181.13 s1.00 s1.32 s1.09 s1.26 s1.24 s1.13 s191.03 s0.88 s0.91 s0.94 s1.19 s1.15 s0.78 s211.42 s1.45 s1.46 s1.47 s1.25 s1.25 s2.22 s221.75 td (13.0,4.9)2.47 dd (13.8,4.8)2.48 dd (13.2,4.8)2.49 m1.59 m1.58 m2.28 td (13.1,4.0)2.81 m2.59 dd (13.5,5.9)2.82 dd (13.6,5.5)1.95 m1.94 m232.48 m6.28 m6.16 m6.29 m1.98 m, 2.05 m1.95 m, 2.04 m244.81 t (6.8)6.09 d (16.0)6.06 d (15.8)6.09 d (15.9)3.97 t (7.1)3.98 t (7.3)265.12 s, 5.29 s1.59 s1.55 s1.60 s1.45 s1.45 s271.94 s1.59 s1.55 s1.60 s1.40 s1.40 s282.03 s1.70 s2.00 s1.17 s1.50 s1.48 s1.68 s291.48 s1.73 s1.46 s1.08 s1.46 s1.42 s1.64 s300.97 s1.34 s1.02 s0.95 s0.85 s0.85 s0.82 s313.54 s[^1][^2][^3]Table 2^13^C NMR (150 MHz, 200 MHz, and 125 MHz in C~5~D~5~N) data for compounds **1**--**7** (*δ* in ppm)Table 2No.1234[a](#tbl2fna){ref-type="table-fn"}567[b](#tbl2fnb){ref-type="table-fn"}139.840.439.440.236.035.639.2228.633.828.434.730.029.533.1378.9219.278.6216.9177.4175.2218.2440.848.240.847.975.275.147.7562.259.562.055.752.852.858.5668.267.368.120.423.423.266.6748.045.947.234.934.334.344.4841.641.042.140.440.940.940.8950.649.354.450.147.547.452.01039.838.640.037.442.342.238.11132.633.340.532.940.340.239.11271.571.3212.371.3210.9210.9209.01348.749.156.749.557.857.857.51452.152.256.052.256.756.754.41531.931.732.331.732.932.831.51627.427.225.027.225.725.725.51755.254.544.854.643.643.647.51817.917.417.916.015.915.915.71918.118.417.817.421.421.317.32073.373.874.073.885.985.8209.92127.728.227.628.225.825.829.92232.440.846.040.836.036.02326.8127.7127.2127.727.427.42490.6138.1138.7138.185.185.125146.781.881.781.871.671.626113.925.625.525.827.027.02717.825.825.725.627.627.52832.532.632.327.334.634.819.92917.020.516.921.628.728.532.03017.516.617.716.517.217.116.83151.7[^4][^5]

2.5. 20(S)-dammar-3-oxo-23-ene-25-hydroperoxyl-6α,12β,20-triol (**2**) {#sec2.5}
----------------------------------------------------------------------

White amorphous powder; \[*a*\]$25\ \text{D}$ +85.8 (*c* 0.19, MeOH); UV (MeOH) λ~max~ (log *ε*) 202 (0.14) nm; IR (KBr) *ν*~max~ 3423, 2966, 2940, 2875, 1693, 1631, 1383; ^1^H and ^13^C NMR data are shown in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}; HR-ESI-MS *m*/*z* 529.3500 \[M+Na\]^+^ (calcd for C~30~H~50~O~6~Na, 529.3500).

2.6. 20(S)-dammar-12-oxo-23-ene-25-hydroperoxyl-3β,6α,20-triol (**3**) {#sec2.6}
----------------------------------------------------------------------

White amorphous powder; \[*a*\]$25\ \text{D}$ +41.1 (*c* 0.34, MeOH); UV (MeOH) λ~max~ (log *ε*) 202 (0.17) nm; IR (KBr) *ν*~max~ 3431, 2971, 2932, 1698, 1630, 1425 cm^−1^; ^1^H and ^13^C NMR data are shown in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}; HR-ESI-MS *m*/*z* 529.3502 \[M+Na\]^+^ (calcd for C~30~H~50~O~6~Na, 529.3505).

2.7. 20(S)-dammar-3-oxo-23-ene-25-hydroperoxyl-12β,20-diol (**4**) {#sec2.7}
------------------------------------------------------------------

White amorphous powder; \[*a*\]$25\ \text{D}$ +19.2 (*c* 0.16, MeOH); UV (MeOH) λ~max~ (log *ε*) 203 (0.27) nm; IR (KBr) *ν*~max~ 3416, 2960, 2934, 2873, 1705, 1630, 1384 cm^−1^; ^1^H and ^13^C NMR data are shown in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}; HR-ESI-MS *m*/*z* 513.3552 \[M+Na\]^+^ (calcd for C~30~H~50~O~5~Na, 513.3550).

2.8. 20(S),24(R)-epoxy-3,4-seco-dammar-25-hydroxy-12-one-3-oic acid (**5**) {#sec2.8}
---------------------------------------------------------------------------

Colorless columnar crystal; \[*a*\]$25\ \text{D}$ +46.5 (*c* 0.16, MeOH); UV (MeOH) λ~max~ (log *ε*) 202 (0.20) nm; IR (KBr) *ν*~max~ 3439, 2879, 1707, 1634, 1384 cm^−1^; ^1^H and ^13^C NMR data are shown in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}; HR-ESI-MS *m*/*z* 529.3504 \[M+Na\]^+^ (calcd for C~30~H~50~O~6~Na, 529.3500).

2.9. 20(S),24(R)-epoxy-3,4-seco-dammar-25-hydroxy-12-one-3-oic acid methyl ester (**6**) {#sec2.9}
----------------------------------------------------------------------------------------

White amorphous powder; \[*a*\]$25\ \text{D}$ +38.8 (*c* 0.17, MeOH); UV (MeOH) λ~max~ (log *ε*) 202 (0.20) nm; IR (KBr) *ν*~max~ 3440, 2969, 1733, 1708, 1630, 1383 cm^−1^; ^1^H and ^13^C NMR data are shown in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}; HR-ESI-MS *m*/*z* 543.3667 \[M+Na\]^+^ (calcd for C~31~H~52~O~6~Na, 543.3662).

2.10. 6α-hydroxy-22,23,24,25,26,27-hexanordammar-3,12,20-trione (**7**) {#sec2.10}
-----------------------------------------------------------------------

Colorless needle crystal; \[*a*\]$25\ \text{D}$ +183.2 (*c* 0.11, MeOH); UV (MeOH) λ~max~ (log *ε*) 203 (0.18), 224 (0.14) nm; IR (KBr) *ν*~max~ 3516, 3436, 2974, 2957, 2876, 1701, 1355 cm^−1^; ^1^H and ^13^C NMR data are shown in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}; HR-ESI-MS *m*/*z* 411.2503 \[M+Na\]^+^ (calcd for C~24~H~36~O~4~Na, 411.2506).

2.11. Inhibition of NO production in RAW264.7 macrophages {#sec2.11}
---------------------------------------------------------

The procedure was carried out as reported previously [@bib13].

2.12. Cytotoxic assay {#sec2.12}
---------------------

The procedure was carried out as reported previously [@bib14].

3. Results and discussion {#sec3}
=========================

3.1. Structure elucidation of compounds **1**--**7** {#sec3.1}
----------------------------------------------------

Compound **1** was presented as white amorphous powder with a molecular formula C~30~H~52~O~6~ based on HR-ESI-MS at *m/z* 531.3659 \[M+Na\]^+^ (calcd for C~30~H~52~O~6~Na, 531.3662). The IR absorptions revealed the existence of hydroxyl (3416 cm^−1^) and double (1631 cm^−1^) bond. In ^1^H NMR spectrum ([Table 1](#tbl1){ref-type="table"}), seven singlet methyl (*δ*~H~ 2.03, 1.94, 1.48, 1.42, 1.13, 1.03, and 0.97, each 3H, s), two olefinic (*δ*~H~ 5.29 and 5.12, each 1H, s), four oxymethine (*δ*~H~ 4.81 \[t, *J* = 6.8 Hz\], and 4.44, 3.95, and 3.56 \[each 1H, m\]), and five oxygen-bearing (*δ*~H~ 12.94, 7.35, 7.09 \[each 1H, s\], 5.83 \[1H, d, *J* = 5.5 Hz\], and 5.36 \[1H, d, *J* = 6.7 Hz\]) proton signals were observed. The ^13^C NMR spectrum showed 30 carbon resonances assignable to seven methyls, nine methylenes with a vinyl (*δ*~C~ 113.9), eight methines with four oxygen-bearing ones (*δ*~C~ 90.6, 78.9, 71.5, and 68.2), and six quaternary carbons with an olefinic (*δ*~C~ 146.7) and an oxygen-bearing (*δ*~C~ 73.3) ones. The NMR data were similar to those of 25,26-en-24(*S*)-hydroperoxyl-20(*S*)-PPD (**14**) [@bib15]. However, the C-6 methylene (*δ*~C~ 19.2) in **14** was replaced by an oxymethine (*δ*~C~ 68.3, *δ*~H~ 4.44), along with the shielding of C-5 (*Δδ*~C~ +5.4 ppm), C-7 (*Δδ*~C~ +4.3 ppm), and C-8 (*Δδ*~C~ +3.6 ppm) in **1**, indicating that **1** was a protopanaxatriol (PPT)-type peroxide analog. The ^1^H-^1^H homonuclear chemical shift correlation spectroscopy. (COSY) of **1** ([Fig. 2](#fig2){ref-type="fig"}) indicated the presence of four fragments: -CH-CH(O)-CH~2~-, -CH-CH~2~-CH(O)-CH-CH-, and two -CH~2~-CH~2~-CH(O)-. In the heteronuclear multiple bond correlation (HMBC) spectrum ([Fig. 2](#fig2){ref-type="fig"}) of **1**, both H~3~-28 (*δ*~H~ 2.03) and H~3~-29 (*δ*~H~ 1.48) were correlated with C-3 (*δ*~C~ 78.9)/C-4 (*δ*~C~ 40.8)/C-5 (*δ*~C~ 62.2), whereas another two methyls of H~3~-18 (*δ*~H~ 1.13) and H~3~-19 (*δ*~H~ 1.03) were correlated withC-7 (*δ*~C~ 48.0)/C-8 (*δ*~C~ 41.6)/C-9 (*δ*~C~ 50.6)/C-14 (*δ*~C~ 52.1) and C-1 (*δ*~C~ 39.8)/C-5/C-9/C-10 (*δ*~C~ 39.8), respectively. Moreover, four hydroxyl protons of 3-OH (*δ*~H~ 5.83), 6-OH (*δ*~H~ 5.36), 12-OH (*δ*~H~ 7.35), and 20-OH (*δ*~H~ 7.09) were correlated with C-2 (*δ*~C~ 28.6)/C-3/C-4, C-5/C-6 (*δ*~C~ 68.2)/C-7, C-11 (*δ*~C~ 32.6)/C-12 (*δ*~C~ 71.5)/C-13 (*δ*~C~ 48.7), and C-17 (*δ*~C~ 55.2)/C-20 (*δ*~C~ 73.3)/C-21 (*δ*~C~ 27.7)/C-22 (*δ*~C~ 32.4), respectively, furnishing the typical PPT core. The position of peroxy group was confirmed to be linked to C-24 from the HMBC correlations of *δ*~H~ 12.94 with C-24 (*δ*~C~ 90.6), combined with the ^1^H-^1^H COSY correlation of 24-OOH with H-24 (*δ*~H~ 4.81).Fig. 2Key ^1^H-^1^H COSY, HMBC, and ROESY correlations of Compound **1**.Fig. 2

The absolute configuration of Compound **1** was determined on the basis of ^13^C NMR, nuclear overhauser effect spectroscopy (ROESY), optional rotation, CD spectra, and biogenetic consideration. Dammarane-type triterpenes derived from the all-chair formed epoxy--squalene requires the *trans*fused rings A/B, B/C, and C/D and *β*-configurations of H-13, CH~3~-18, CH~3~-19, and the side chain at C-17 on its tetracyclic skeleton [@bib16]. The 3*β*-OH in **1** was firstly identified by the chemical shift of C-3 (*δ*~C~ 78.9), which was *ca.* 2.8 ppm upfield shifted, related to those of the 3*α*-OH derivatives [@bib17]. In the ROESY spectrum of **1** ([Fig. 2](#fig2){ref-type="fig"}), H-6 (*δ*~H~ 4.44) and H-12 (*δ*~H~ 3.95) were correlated with the two *β*-methyls of H~3~-18 and H~3~-19, and H-9 (*δ*~H~ 1.62), H-17 (*δ*~H~ 2.36), and α-methyl of H~3~-30, respectively, indicating the 6*α* and 12*β* hydroxy groups of **1**. Moreover, compared with the 20*R* configuration (C-17 \[*δ*~C~ 50.7\] and C-21 \[*δ*~C~ 22.8\]), the obviously deshielded C-17 (*δ*~C~ 55.2) and C-21 (*δ*~C~ 27.7) revealed the 20*S* configuration in **1** [@bib17], [@bib18]. The 24*S* configuration for **1** was determined by comparing the \[α\]~D~ value with that of **14** and the negative Cotton effect at 216 nm for both **1** and **14** (**S2**). On the basis of the aforementioned evidence, Compound **1** was deduced to be 20(*S*)-dammar-25-ene-24(*S*)-hydroperoxyl-3*β*,6*α*,12*β*,20-tetrol.

Compound **2** possessed a molecular formula C~30~H~50~O~6~, as deduced by the HR-ESI-MS at *m/z* 529.3500 \[M+Na\]^+^ (calcd for C~30~H~50~O~6~Na, 529.3500) and the distortionless enhancement by polarization transfer (DEPT) spectrum, corresponding to six degrees of unsaturation. The NMR data ([Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}) of **2** showed some similarity to those of **1**. However, a ketone (*δ*~C~ 219.2), a *trans*disubstituted double bond (*δ*~C~ 138.1, *δ*~H~ 6.09 \[d 16.0\] and *δ*~C~ 127.7, *δ*~H~ 6.28 \[m\]), and an oxy-quaternary carbon (*δ*~C~ 81.8) that appeared in **2** were replaced by an oxymethine (C-3, *δ*~C~ 78.9), a terminal double bond between C-25 and C-26 (*δ*~C~ 146.7, 113.9), and a peroxylated methine of C-24 (*δ*~C~ 90.6) in **1**. These NMR features were in good agreement with those of **17** [@bib19], except for an additional ketone in **2**, indicating **2** was a C-3-oxidized PPT-type peroxide analog. This deduction was verified by the HMBC correlations from H-2 (*δ*~H~ 2.84, 2.31), H-28 (*δ*~H~ 1.70), and H-29 (*δ*~H~ 1.73) to C-3 (*δ*~C~ 219.2), along with the ROESY correlations of H-6 (*δ*~H~ 4.25) with H-18 (*δ*~H~ 0.88) and H-19 (*δ*~H~ 1.00) and H-12 (*δ*~H~ 3.95) with H-9 (*δ*~H~ 1.71), H-17 (*δ*~H~ 2.40), and H-30 (*δ*~H~ 1.34). Thus, Compound **2** was characterized as 20(*S*)-dammar-3-oxo-23-ene-25-hydroperoxyl-6*α*,12*β*,20-triol.

Compound **3** had a molecular formula C~30~H~50~O~6~, as determined by positive-mode HR-ESI-MS at *m/z* 529.3502 \[M+Na\]^+^ (calcd for C~30~H~50~O~6~Na, 529.3505). The ^1^H and ^13^C NMR data, indicating a ketone (*δ*~C~ 219.2) and a *trans*disubstituted double bond (*δ*~C~ 138.7, *δ*~H~ 6.06 \[d 15.8\], *δ*~C~ 127.2, and *δ*~H~ 6.16 \[m\]), were quite similar to those of **2**. The C-3 ketone (*δ*~C~ 219.2) and C-12 oxymethine (*δ*~C~ 71.3) in **2** were upfield and downfield shifted to *δ*~C~ 212.3 and *δ*~C~ 78.6 in **3**, respectively, indicating the location of the ketone group in **3** and **2** was different. The ^1^H-^1^H COSY correlations between H-3 (*δ*~H~ 3.51) and H-2 (*δ*~H~ 1.87)/3-OH (*δ*~H~ 5.85), and HMBC correlations from H-2/H-28 (*δ*~H~ 2.00)/H-29 (*δ*~H~ 1.46) to C-3 (*δ*~C~ 78.6) and from H~2~-11 (*δ*~H~ 2.40, 2.37)/H-13 (*δ*~H~ 3.37)/H-17 (*δ*~H~ 2.74) to C-12 ketone (*δ*~C~ 212.3) revealed that **3** was a C-12-oxidized PPT-type peroxide analog. Compound **3** was therefore identified as 20(*S*)-dammar-12-oxo-23-ene-25-hydroperoxyl-3*β*,6*α*,20-triol.

Compound **4** showed a molecular formula C~30~H~50~O~5~, based on HR-ESI-MS at *m/z* 513.3552 \[M+Na\]^+^ (calcd for C~30~H~50~O~5~Na, 513.3550). It also showed coherent NMR data ([Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}) to **2**, excepting the appearance of a methylene (*δ*~C~ 20.4) in **4** instead of the oxymethine (*δ*~C~ 67.3 \[C-6\], *δ*~H~ 5.78 \[6-OH\]) in **2**. When taking the molecular weight (16 Da less than **2**) into consideration, the disappearance of a hydroxyl group at C-6 was reasonably deduced for **4**, suggesting **4** to be a C-3-oxidized PPD-type peroxide derivative. The ^1^H-^1^H COSY correlations of H~2~-6 (*δ*~H~ 1.50, 1.42) with H-5 (*δ*~H~ 1.38)/H~2~-7 (*δ*~H~ 2.51, 1.28) and H-12 (*δ*~H~ 3.93) with H-13 (*δ*~H~ 2.08) together with the HMBC correlations from H~2~-6 to C-5 (*δ*~C~ 55.7)/C-6 (*δ*~C~ 20.4)/C-7 (*δ*~C~ 34.9) and Ha-2 (*δ*~H~ 2.46)/H-28 (*δ*~H~ 1.17)/H-29 (*δ*~H~ 1.08) to C-3 (*δ*~C~ 216.9) further confirmed the structure of **4**. Accordingly, Compound **4** was determined to be 20(*S*)-dammar-3-oxo-23-ene-25-hydroperoxyl-12*β*,20-diol.

Compound **5**, a colorless columnar crystal, had a molecular formula C~30~H~50~O~6~ determined by the *m/z* 529.3504 \[M+Na\]^+^ (calcd for C~30~H~50~O~6~Na, 529.3500). Its NMR spectra, combined with heteronuclear single quantum correlation (HSQC) spectra, showed 30 carbon resonances and were similar to those of an ocotillol-type triterpene, 20*S*,24*R*-epoxy-dammar-3*β*,6*α*,25-triol-12-one (**29**) [@bib20], featuring a 20,24-epoxylated hydroxyisopropyl-tetrahydrofuran side chain at the C-20, except for the signals of A-ring. The carbonyl signal (*δ*~C~ 177.4) and an additional oxy-quaternary carbon at *δ*~C~ 75.2 suggested that the A-ring cleavage in **5** retained an open form with a carboxylic acid residue. This illation was confirmed by ^1^H-^1^H COSY correlations of H~2~-1 with H-2 and H-6 with H-5/H-7, as well as the HMBC correlations of H-5/H-6/H-28/H-29 with C-4 and H-1/H-2 with C-3 (*δ*~C~ 177.4). So far, all ocotillol-type triterpenes isolated from *Panax* species possessed a 20*S* configuration [@bib21], which could be recognized by the obvious differences for C-17, C-20, and C-21 between 20(*S*) and 20(*R*) configurations [@bib22]. A clear triplet (*J* = 7.1 Hz) H-24 indicated the 24*R* configuration for **5**, when comparing with the 24*S* configuration (dd, *J* = 10.0, 5.5 Hz) [@bib23]. Finally, the structure of **5** was unequivocally confirmed by the oak ridge thermal ellipsoid of plot (ORTEP) drawing of X-ray crystallography analysis ([Fig. 3](#fig3){ref-type="fig"}) to be 20(*S*),24(*R*)-epoxy-3,4-*seco*-dammar-25-hydroxy-12-one-3-oic acid.Fig. 3ORTEP of **5** and **7** with thermal ellipsoids shown at 30% probability.Fig. 3

Compound **6** had a molecular formula of C~31~H~52~O~6~, as deduced by the HR-ESI-MS at *m/z* 543.3667 \[M+Na\]^+^ (calcd for C~31~H~52~O~6~Na, 543.3662). The ^13^C NMR spectrum showing the existence of 31 carbons was closely similar to that of **5**, except for an additional methoxy carbon (*δ*~C~ 51.7, *δ*~H~ 3.54) and an upper-field shifted carbonyl carbon (*Δδ*~C~ −2.2 ppm) in **6**. These NMR characteristics suggested that the carboxylic acid in **5** was esterified to methyl ester in **6**. Furthermore, HMBC correlation from -OCH~3~ (*δ*~H~ 3.54) to C-3 (*δ*~C~ 175.2) and of the same negative Cotton effects at 220 and 285 nm with those of **5** (**S3**) confirmed the structure of **6**. Hence, Compound **6** was elucidated to be 20(*S*),24(*R*)-epoxy-3,4-*seco*-dammar-25-hydroxy-12-one-3-oic acid methyl ester.

Compound **7** was isolated as colorless needle crystal and had a molecular formula of C~24~H~36~O~4~, as determined by the HR-ESI-MS at *m/z* 411.2503 \[M + Na\]^+^ (calcd for C~24~H~36~O~4~Na, 411.2506) in the HR-ESI-MS spectrum, referring to seven degrees of unsaturation. IR absorptions for hydroxy (3516 cm^−1^) and carbonyl (1701 cm^−1^) groups were observed effortlessly. The ^13^C NMR and DEPT spectra of **7**, showing the existence of six methyls, six methylenes, four methines with one oxymethine (*δ*~C~ 66.6), and seven quaternary carbons with three ketones (*δ*~C~ 218.2, 209.9, 209.0), were consistent with those of panaxadione (**30**) [@bib24], except for the absence of the signals from the side chain (C-20 to C-27) and appearance of an additional ketone (*δ*~C~ 209.0). Considering the molecular weight, it can be inferred that the side chain of Compound **7** was lost and left with a methyl ketone structure. The above analysis was confirmed by the HMBC correlations of H-13/H-17/H-21 to C-20 (*δ*~C~ 209.9). The stereochemistry of C-17 was established as *S* configuration by the ROESY correlation of H-17 with H-30 first and X-ray crystallography analysis finally ([Fig. 3](#fig3){ref-type="fig"}). Consequently, Compound **7** was deduced to be 6*α*-hydroxy-22,23,24,25,26,27-hexanordammar-3,12,20-trione.

3.2. Structure identification of known compounds **8**--**30** {#sec3.2}
--------------------------------------------------------------

Twenty-three known triterpenes and saponins were identified as 20(*S*)-PPD (**8**) [@bib25], 20(*S*)-PPT (**9**), 20(*S*)-ginsenoside Rh1 (**10**) [@bib26], 20(*S*)-dammar-3-oxo-24-ene-6*α*,12*β*,20-triol (**11**) [@bib27], 6*α*,20(*S*)-dihydroxydammar-3,12-dione-24-ene (**12**) [@bib28], 25,26-en-24(*R*)-hydroperoxyl-20(*S*)-PPD (**13**), 25,26-en-24(*S*)-hydroperoxyl-20(*S*)-PPD (**14**) [@bib15], 20(*S*)-ginsenoside SL1 (**15**) [@bib29], 23,24-en-25-hydroperoxyl-20(*S*)-PPD (**16**) [@bib15], 20(*S*)-dammar-23-ene-25-hydroperoxyl-3*β*,6*α*,12*β*,20-tetrol (**17**) [@bib19], 20(*S*)-floralquinquenoside A (**18**) [@bib30], 20(*S*)-dammar-23-ene-3*β*,12*β*,20,25-tetrol (**19**) [@bib31], 20(*S*),23(*E*)-ginsenoside Rh13 (**20**) [@bib32], 20(*S*)-dammar-23-ene-3*β*,6*α*,12*β*,20,25-pentanol (**21**) [@bib33], 6*α*,20(*S*),25-trihydroxy-dammar-3,12-dione-23-ene (**22**) [@bib28], 25,26-en-24(*R*)-hydroxyl-20(*S*)-PPD (**23**) [@bib31], 20(*S*), 24(*S*)-dammar-25(26)-ene-3*β*,6*α*,12*β*,20,24-pentanol (**24**) [@bib19], 20(*S*), 24(*R*)-dammar-25(26)-ene-3*β*,6*α*,12*β*,20,24-pentanol (**25**) [@bib34], 20(*S*),24(*R*)-dammar-20,24-epoxy-3*β*,6*α*,12*β*,25-tetrol (**26**) [@bib21], 20(*S*),24(*R*)-dammar-3-one-20,24-epoxy-6*α*,12*β*,25-triol (**27**) [@bib35], 20(*S*), 24(*S*)-dammar-3-one-20,24-epoxy-6*α*,12*β*,25-triol (**28**), 20(*S*),24(*R*)-epoxy-dammar-3*β*,6*α*, 25-triol-12-one (**29**) [@bib20], and panaxadione (**30**) [@bib24] by comparing with the NMR and MS data with literature values. Among them, **10**, **15**, **18,** and **20** were saponins, and **12**--**16** and **19**--**25** were reported in Sanqi for the first time.

3.3. Antiinflammatory and cytotoxic activities {#sec3.3}
----------------------------------------------

All isolates were evaluated for inhibition of NO production in murine macrophage cell line RAW264.7 (antiinflammatory) and cytotoxicity against five human cancer cell lines (breast cancer MCF-7, colon cancer SW480, hepatocellular carcinoma SMMC7721, lung cancer A-549, and myeloid leukemia HL-60).

As shown in [Table 3](#tbl3){ref-type="table"}, the new Compound **1** showed comparable antiinflammatory activity (half maximal inhibitory concentration IC~50~ = 42.47 ± 0.49 μM) to the positive control, L-NMMA (IC~50~ = 39.26 ± 0.91 μM), whereas **13** and **14** showed stronger inhibitory effects on NO production (IC~50~ = 17.18 ± 0.35 \[**13**\] and 25.87 ± 0.60 \[**14**\] μM). It was noted that the PPD analog showed stronger antiinflammatory activity than the PPT analog and triterpenes are superior to their saponins. Moreover, C-24-OOH is essential for the inhibition of NO production and 24*R* configuration is stronger than 24*S* configurations.Table 3Antiinflammatory activities (uM) of compounds **1**, **13**, and **14**Table 3CompoundIC~50~ ± SD**1**42.47 ± 0.49**13**17.18 ± 0.35**14**25.87 ± 0.60L-NMMA39.26 ± 0.91[^6][^7]

At a concentration of 40 μM, most isolates showed no cytotoxicities. Only compound **9** showed moderate cytotoxicities against all five cancer cells ([Table 4](#tbl4){ref-type="table"}). Moreover, **13** showed toxicities on HL-60, A-549, and SW480 cell lines, whereas **12** and **16** showed cytotoxicities against only HL-60 cells.Table 4Cytotoxicities (μM) of compounds **9**, **12**, **13**, and **16**Table 4CompoundIC~50~ ± SDMyeloid leukemia HL-60Lung cancer A-549Hepatocellular carcinoma SMMC7721Breast cancer MCF-7Colon cancer SW480**9**16.58 ± 0.3434.38 ± 0.4224.16 ± 0.6717.06 ± 0.6717.00 ± 0.37**12**27.37 ± 1.72\> 100\> 100\> 100\> 100**13**16.13 ± 0.4230.86 ± 0.91\> 100\> 10026.79 ± 0.31**16**12.37 ± 0.48\> 100\> 100\> 100\> 100DDP2.61 ± 0.0717.80 ± 0.5910.42 ± 0.4419.44 ± 1.5620.80 ± 1.04Taxol\< 0.008\< 0.008\< 0.008\< 0.008\< 0.008[^8][^9]

4. Conclusion {#sec4}
=============

In summary, 30 dammarane-type triterpenes and saponins including 10 hydroperoxylated (**1**--**4** and **13**--**18**), seven 20,24-epoxylated (**5**--**6** and **26**--**30**), and one losing of the side chain (**7**) analogs were identified from the rot roots of *P. notoginseng*. Seven of them, **1**--**7**, are new compounds. Most compounds are sapogenins, and their oxidation level was increased, which was consistent with the analytic results in the previous report [@bib8]. The new Compound **1** showed comparable antiinflammatory activity to the positive control, but weaker than the known triterpenes **13** and **14**. Moreover, Compounds **9**, **12**, **13**, and **16** showed moderate cytotoxicities against five human cancer cells. The investigation will provide valuable information in understanding the chemical constituents of Sanqi rot roots and searching new candidates for antiinflammatory and antitumor agents. Studies of the plant itself and the isolates against pathogenic microorganisms of the titled plant are now on progress, which may provide the basic theory for chemical and biological control of root rot disease of the titled herb.
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[^1]: d: doublet; m: multiplet; s: singlet; t: triplet

[^2]: 800 MHz.

[^3]: 500 MHz.

[^4]: 200 MHz.

[^5]: 125 MHz.

[^6]: SD, standard deviation

[^7]: Data are expressed as means ± SD (n = 3)

[^8]: SD, standard deviation; DDP, cisplatin

[^9]: Data are expressed as means ± SD (n = 3)
